CLINICAL_TRIALS
trial_result
· 2020-11-30
Clinical Trial Update: Multiple Escalating Dose Study of BAY1093884 in Adults With Hemophilia A or B With or Without Inhibitors [Phase 2]
Summary
Phase 2 study of BAY1093884 in adults with Hemophilia A or B with or without inhibitors was terminated; results posted in 2020.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bayer | Conditions: Hemophilia A and B | Phase 2 | Status: TERMINATED | Results posted: 2020-11-30